6838 Formosa Pharmaceuticals: Announcement of Lifting Non-Compete Restrictions for Directors (Including Independent Directors)
Formosa Pharmaceuticals held its annual general meeting on May 25, 115, and approved the lifting of non-compete restrictions for Director Ma Hai-Yi and Independent Director Lo Li-Chu. Ma is permitted to serve as an independent director at Acepodia, and Lo is permitted to serve as an independent director at An-Bang Biotech. The motion passed with 98.72% approval.
📋 Article Processing Timeline
- 📰 Published: May 26, 2026 at 06:31
- 🔍 Collected: May 26, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 31, 2026 at 20:19 (133h 47m after Collected)
On May 25, 115, Formosa Pharmaceuticals, Inc. held its annual general meeting and passed a resolution to lift the non-compete restrictions for Director Ma Hai-Yi and Independent Director Lo Li-Chu. Ma Hai-Yi is permitted to serve as an independent director at Acepodia, Inc. (Cayman Islands), and Lo Li-Chu is permitted to serve as an independent director at An-Bang Biotech Co., Ltd. This permission applies for the duration of their tenure as directors at Formosa Pharmaceuticals. The resolution was passed with 98.72% of the voting rights present at the meeting in favor, as per the original proposal.
FAQ
When was the non-compete restriction lifted?
It was approved at the shareholder meeting on May 25, 115.